T cells engineered to carry a high-affinity HBV-specific T cell receptor: a potent weapon against advanced HBV-related HCC

Thimme R, Neumann-Haefelin C. 2025. T cells engineered to carry a high-affinity HBV-specific T cell receptor: a potent weapon against advanced HBV-related HCC. Gut. 2025: gutjnl-2025-336452. doi: 10.1136/gutjnl-2025-336452.

Categorised in:

This post was written by Heike Ufheil